Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
<p><strong>Background: </strong>Deprescribing of antihypertensive medications is recommended for some older patients with low blood pressure and frailty. The OPTiMISE trial showed that this deprescribing can be achieved with no differences in blood pressure control at 3&am...
Main Authors: | Sheppard, JP, Temple, E, Wang, A, Smith, A, Pollock, S, Ford, GA, Hobbs, FDR, Kenealy, N, Little, P, Lown, M, de Lusignan, S, Mant, J, McCartney, D, Payne, RA, Williams, M, Yu, L-M, McManus, RJ |
---|---|
Other Authors: | OPTiMISE Investigators |
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2024
|
Similar Items
-
Cost-effectiveness of antihypertensive deprescribing in primary care: a Markov modelling study using data from the OPTiMISE trial
by: Jowett, S, et al.
Published: (2022) -
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
by: James P Sheppard, PhD, et al.
Published: (2024-08-01) -
Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
by: Sheppard, J, et al.
Published: (2024) -
Blood pressure changes following antihypertensive medication reduction, by drug class and dose chosen for withdrawal: exploratory analysis of data from the OPTiMISE trial
by: Sheppard, J, et al.
Published: (2021) -
Deprescribing antihypertensive medication in elderly adults - Reply
by: Sheppard, JP, et al.
Published: (2020)